Report title: DIABETES ISSUE REPORT - TARGETING DISEASE PREVENTION
from TF Market Research
23 page report published Jun 17, 2002

Price $1,840.00 available for immediate download
This report is also available for purchase on a per-page basis.
Report Overview
 
Purchase by Section
 
About TF Market Research

Source: DATAMONITOR PREMIUM REPORTS
Geographic Region: INTERNATIONAL
Industries: HEALTH CARE, PHARMACEUTICALS
Format:
PDF Adobe Acrobat

Sections
TitleStarting PageNumber of Pages
Diabetes Issue Report11
CHAPTER 1 TARGETING DISEASE PREVENTION11
1.1 Introduction13
1.2 Current and future prevalence of diabetes41
1.3 Impact of Diabetes on Cardiovascular Risk61
Mechanism of increased cardiovascular risk61
Insulin resistance syndrome71
1.4 Diabetes and hypertension: A lethal combination91
Hypertension and insulin resistance91
Type 1 diabetics91
Type 2 diabetics101
Obesity101
Current and future prevalence of diabetic hypertension111
Prevalence of diabetic hypertension in the seven major markets 2001111
Increased risk associated with diabetic hypertension121
1.5 Commercial implications131
Increased awareness of diabetes drives market growth142
Focus on diabetes prevention and CVD risk reduction152
1.6 Companies taking the lead161
ACE inhibitors and AIIRBs demonstrating renoprotection in type 1 and type 2 diabetics161
ACE inhibitor Altace (ramipril) demonstrating greater cardioprotection in type 2 diabetics171
Anti-obesity therapies trialed as adjunctive therapy for treatment of type 2 diabetes171
Novarits181
NAVIGATOR trial: Starlix (nateglinide) and Diovan (valsartan)181
Study protocol181
Expanding patient potential through early intervention182
Aventis191
DREAM trial: Altace (ramipril) and Avandia (rosiglitazone)191
GlaxoSmithKline201
Avandia (rosiglitazone) for the prevention of cardiovascular disease201
Clinical trials201
1.7 Companies facing unexploited opportunities211
Takeda221
Sankyo221
Bristol-Myers Squibb221
AstraZeneca231
1.8 Looking Ahead231

Price: $1,840.00



  Get FREE Research

Sign up here to receive email alerts for FREE Research from Alacra Partners!


  Can't Decide?

Purchasing premium research sight unseen can be intimidating. We want you to know what you are getting. Visit our FAQ or ask our Customer Service Team any questions about the report you are considering purchasing.